Fluoride Ion

Fluoride Ion

SCHEMBL775334

[F-].[F-].[F-].[Na+].[Na+].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Fluoride Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride Ion SCHEMBL28698761 1.00 CA4 (0.50)
Fluoride Ion SCHEMBL29203899 1.00 CA4 (0.50)
Fluoride Ion SCHEMBL27849659 1.00 CA4 (0.50)
Fluoride Ion SCHEMBL2785839 1.00 CA4 (0.50)
Fluoride Ion SCHEMBL2348 1.00
Fluoride Ion SCHEMBL1782157 1.00
Fluoride Ion SCHEMBL3823213 1.00
Fluoride Ion F-18 SCHEMBL29392639 1.00
Fluoride Ion SCHEMBL2698068 0.82
Fluoride Ion SCHEMBL290863 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117605388-A Fireproof and moistureproof solid wood door and production process thereof 贵州大学 2024-02-27 CN claimed
US-5364434-A Plasma treatment of glass surfaces to remove carbon THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1994-11-15 US claimed
WO-2025050284-A1 HIGH-CONCENTRATION HIGH-ENTROPY ELECTROLYTE AND PREPARATION METHOD THEREFOR, AND BATTERY 昆明理工大学 2025-03-13 WO disclosed
CN-119018864-A Method for producing trisodium phosphate by using mixed rare earth ore 四川省乐山锐丰冶金有限公司 2024-11-26 CN disclosed
CN-115867255-B Collagen production promoter and external preparation for skin containing the same 一丸自然美健有限公司 2024-10-25 CN disclosed
CN-118772110-A Heteroarone compounds and their use as LSD1 inhibitors 上海复星医药(集团)股份有限公司 2024-10-15 CN disclosed
CN-117728030-A Sodium metal battery electrolyte and sodium metal battery 蓝固(湖州)新能源科技有限公司 2024-03-19 CN disclosed
CN-117605388-A Fireproof and moistureproof solid wood door and production process thereof 贵州大学 2024-02-27 CN disclosed
CN-117413406-A High-concentration high-entropy electrolyte, preparation method thereof and battery 昆明理工大学 2024-01-16 CN disclosed
CN-114469965-B Inhibitors of core fucosyltransferase and application thereof 大连医科大学 2023-09-12 CN disclosed
CN-113773246-B Preparation method of 2-substituted-4-trifluoromethylpyridine 山东省农药科学研究院 2023-03-31 CN disclosed
EP-3826619-A1 PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE Bayer Aktiengesellschaft (DE) 2021-06-02 EP disclosed
CN-107759624-B Asymmetric aryl boron organic photoelectric functional material and preparation method and application thereof 南京邮电大学 2020-08-04 CN disclosed
WO-2020020789-A1 PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE BAYER AKTIENGESELLSCHAFT (DE) 2020-01-30 WO disclosed
WO-2020020790-A1 PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE BAYER AKTIENGESELLSCHAFT (DE) 2020-01-30 WO disclosed
CN-104515826-A Method for determination of tin content in tin-lead solder by complexometric titration method JIANGXI HONGDU AVIAT IND GROUP 2015-04-15 CN disclosed
US-8853390-B2 Processes for preparing 1,2-substituted cyclopropyl derivatives ABBVIE INC. (US) 2014-10-07 US disclosed
WO-2012037258-A1 PROCESSES FOR PREPARING 1,2-SUBSTITUTED CYCLOPROPYL DERIVATIVES ABBOTT LABORATORIES (US) 2012-03-22 WO disclosed
US-20120071651-A1 Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives ABBOTT LABORATORIES (US) 2012-03-22 US disclosed
US-20060122337-A1 Polyester amide copolymer, and moldings and production processes of the copolymer KUREHA CORPORATION (JP) 2006-06-08 US disclosed